Abstract
Amaç: Tiroid kanserleri çok defa
karşımıza soliter hipoaktif bir nodül olarak çıkmakta ancak bu nodülün
malignite tanısı koyulmasındaki bir takım güçlükler uygulanan cerrahi girişim
seçimini de zorlaştırmaktadır. Tiroid kanseri tanısı ile opere
edilen hastalarda tiroid kanser tanısı ve tedavisinin uygulanması için gerekli
cerrahi yöntem tercihini belirlemek amacıyla bu çalışmaya yöneldik.
Gereç
ve Yöntem: Haseki Eğitim ve Araştırma Hastanesi Cerrahi Kliniğinde opere edilen
toplam 40 tiroid kanseri hastasının verileri incelendi. Bu hastaların başvuru
yakınmaları ve radyolojik görüntüleme bulguları, laboratuar sonuçları, yapılan
cerrahi girişim verileri incelenmiştir.
Bulgular:
40 tiroid kanseri hastasının 25’i (%62.5) kadın, 15’i (%27.5) erkek idi. Kadın
hastaların 23'ü (%92), erkek hastaların 13'ü (%86.6) ötiroid idi. Hastalarımızın
29 (%72.5)’u papiller kanser, 5 (%12.5)’i folliküler kanser, 2 (%5)’si medüller
kanser, 3 (%7.5)’ü anaplastik kanser ve 1 (%2.5)’i hurthle hücreli karsinom
idi.
Sonuç: Tiroid kanseri cerrahisindeki değişikliklerin fazlalığı, hatta çoğu
tiroid kanserinin takip edilmesi sonucu grupların oluşması, total tiroidektomi
ve lobektomi arasında evrilen cerrahi, bu tür çalışmaların varlığının değerli
olduğunu düşündürmektedir.
Keywords
References
- Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet 2016;3;388(10061):2783-2795.
- Takano T. Natural history of thyroid cancer. Endocr J 2017;31;64(3):237-244.
- Albi E, Cataldi S, Lazzarini A, Codini M, Beccari T, Ambesi-Impiombato FS, et al. Radiation and Thyroid Cancer. Int J Mol Sci 2017;26;18(5).
- Schmidt A, Iglesias L, Klain M, Pitoia F, Schlumberger MJ. Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation. Arch Endocrinol Metab 2017;61(1):81-89.
- Nabhan F, Ringel MD. Thyroid nodules and cancer management guidelines: comparisons and controversies. Endocr Relat Cancer 2017;24(2):13-26.
- Accardo G, Conzo G, Esposito D, Gambardella C, Mazzella M, Castaldo F, et al. Genetics of medullary thyroid cancer: An overview. Int J Surg 2017;41 Suppl 1:S2- S6.
- Schmidbauer B, Menhart K, Hellwig D, Grosse J. Differentiated Thyroid Cancer-Treatment: State of the Art. Int J Mol Sci 2017;17:18(6).
- Roman BR, Morris LG, Davies L. The thyroid cancer epidemic, perspective. Curr Opin Endocrinol Diabetes Obes 2017;24(5):332-336.
- Chowdhury S, Mukherjee S, Mukhopadhyay S, Mazumder R. The thyroid nodule evaluation and management. J Indian Med Assoc 2006;104(10):568-70,572-3.
- Christou N, Mathonnet M. Complications after total thyroidectomy. J Visc Surg 2013;150(4):249-56.
- Eroğlu A, Berberoğlu U, Buruk F, Yildirim E. Completion thyroidectomy for differentiated thyroid carcinoma. J Surg Oncol 1995;59(4):261-7.
Abstract
Objectives:
Thyroid cancers often appear as a solitary hypoactive nodule, but several difficulties
in diagnosing malignancy of this nodule also make it difficult to choose the
correct surgical intervention. We turned to this study to determine the choice
of a surgical method for the diagnosis and treatment of thyroid cancer in
patients who are operated with a thyroid cancer diagnosis.
Material
and Method: The data of a total of 40 thyroid cancer patients who were conducted
at Haseki Training and Research Hospital Surgical Clinic were examined. The patients'
admission complaints and radiological imaging findings, laboratory results and
surgical intervention data were examined.
Results:
Of the 40 thyroid cancer patients, 25 (62.5%) were female and 15 (27.5%) were
male. Twenty-three (92%) of female patients and 13 (86.6%) were euthyroid. 29
(72.5%) of our patients had papillary cancer, 5 (12.5%) follicular cancer, 2
(5%) medullary cancer, 3 (7.5%) anaplastic cancer and 1 (2.5%) hurthle cell
carcinoma.
Conclusion:
The excessive changes in thyroid cancer surgery, even the formation of groups
as a result of the follow-up of most thyroid cancers, the surgery that evolved
between total thyroidectomy and lobectomy suggest that the existence of such
studies is valuable.
Keywords
References
- Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet 2016;3;388(10061):2783-2795.
- Takano T. Natural history of thyroid cancer. Endocr J 2017;31;64(3):237-244.
- Albi E, Cataldi S, Lazzarini A, Codini M, Beccari T, Ambesi-Impiombato FS, et al. Radiation and Thyroid Cancer. Int J Mol Sci 2017;26;18(5).
- Schmidt A, Iglesias L, Klain M, Pitoia F, Schlumberger MJ. Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation. Arch Endocrinol Metab 2017;61(1):81-89.
- Nabhan F, Ringel MD. Thyroid nodules and cancer management guidelines: comparisons and controversies. Endocr Relat Cancer 2017;24(2):13-26.
- Accardo G, Conzo G, Esposito D, Gambardella C, Mazzella M, Castaldo F, et al. Genetics of medullary thyroid cancer: An overview. Int J Surg 2017;41 Suppl 1:S2- S6.
- Schmidbauer B, Menhart K, Hellwig D, Grosse J. Differentiated Thyroid Cancer-Treatment: State of the Art. Int J Mol Sci 2017;17:18(6).
- Roman BR, Morris LG, Davies L. The thyroid cancer epidemic, perspective. Curr Opin Endocrinol Diabetes Obes 2017;24(5):332-336.
- Chowdhury S, Mukherjee S, Mukhopadhyay S, Mazumder R. The thyroid nodule evaluation and management. J Indian Med Assoc 2006;104(10):568-70,572-3.
- Christou N, Mathonnet M. Complications after total thyroidectomy. J Visc Surg 2013;150(4):249-56.
- Eroğlu A, Berberoğlu U, Buruk F, Yildirim E. Completion thyroidectomy for differentiated thyroid carcinoma. J Surg Oncol 1995;59(4):261-7.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Original Research |
| Authors | |
| Publication Date | December 15, 2019 |
| Published in Issue | Year 2019 |